npj Genomic Medicine · 2024 · 16 citations · 38 references
Life SciencesGeneticsInsuranceGenetic EpidemiologyHuman GeneticsMedical GeneticsGenetic Research EthicsGenetic RiskGenetic Risk AssessmentGenetic Risk FactorsLife Insurance UnderwritingPolygenic Risk AssessmentGenetic DiscriminationGenetic Information UnderwritingGenetic TestingRare Genetic Variants
The use of genetic risk information in life insurance underwriting is a major ethical, legal, and psychosocial concern 1 , 2 , 3 , 4 . Genetic discrimination (GD) is defined as the “ differential treatment of asymptomatic individuals or their relatives on the basis of real or assumed genetic differences or characteristics ” 3 . In life insurance underwriting, GD stems from the use of genetic risk information to deny coverage, increase premiums, or place conditions on products such as disability, death, trauma and income protection cover 5 . Reports of insurance discrimination among individuals with rare variants in monogenic risk genes are well described, including insurance providers denying coverage or increasing premiums based on positive results, even when individuals take steps to mitigate risk 5 , 6 , 7 , 8 , 9 . However, it is difficult to quantify the prevalence of GD due to methodological challenges such as ability to obtain data from insurance industry, thus, most research to date has relied on self-reported experiences. Nevertheless, fear of GD remains a deterrent to uptake of genetic testing in clinical and research settings 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 . With the emergence and increased use of new genetic technologies it is essential that we consider the unique challenges that may arise regarding GD.
38
The National Comprehensive Cancer Network
William T. McGivney · Cancer · 1998 · 16.9K citations
Testing for Adverse Selection in Insurance Markets
Alma Cohen, Peter Siegelman · Journal of Risk & Insurance · 2009 · 433 citations